Showing 1 - 10 of 13
Persistent link: https://www.econbiz.de/10012082424
This study examines the impact that private financing of prescription drugs in Canada has on equity in the utilization of publicly financed physician services. The complementary nature of prescription drugs and physician service use alongside the reliance on private finance for drugs may induce...
Persistent link: https://www.econbiz.de/10008542730
The Greek health system does not yet offer universal coverage and has fragmented funding and delivery. Funding is regressive, with a reliance on informal payments, and there are inequities in access, supply and quality of services. Inefficiencies arise from an over reliance on relatively...
Persistent link: https://www.econbiz.de/10005792802
The French government introduced a 'free complementary health insurance plan' in 2000, which covers most of the out-of-pocket payments faced by the poorest 10% of French residents. This plan was designed to help the non-elderly poor to access health care. To assess the impact of the introduction...
Persistent link: https://www.econbiz.de/10005200001
In France, public health insurance is universal but incomplete, with private payments accounting for roughly 25% of all spending. As a result, most people have supplemental private health insurance. We investigate the effects of such insurance on the utilization of physician services using data...
Persistent link: https://www.econbiz.de/10005694165
In this paper we evaluate the respective effects of demographic change, changes in morbidity and changes in practices on growth in health care expenditures. We use microdata, i.e. representative samples of 3441 and 5003 French individuals observed in 1992 and 2000. Our data provide detailed...
Persistent link: https://www.econbiz.de/10005694178
ABSTRACT This study exploits a natural experiment in the province of Ontario, Canada, to identify the impact of pay‐for‐performance (P4P) incentives on the provision of targeted primary care services and whether physicians' responses differ by age, size of patient population, and baseline...
Persistent link: https://www.econbiz.de/10011005327
Persistent link: https://www.econbiz.de/10011005343
Persistent link: https://www.econbiz.de/10010545862
The price elasticity of demand for prescription drugs is a crucial parameter of interest in designing pharmaceutical benefit plans. Estimating the elasticity using micro-data, however, is challenging because insurance coverage that includes deductibles, co-insurance provisions and maximum...
Persistent link: https://www.econbiz.de/10005689839